2-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-oxoethyl 2-(4-hydroxy-1-oxophthalazin-2(1H)-yl)acetate

Catalog No. :
ACULVT358
CAS No. :
848316-39-2
Molecular Formula :
C20H16N2O7
Molecular Weight :
396.36

IUPAC Name:2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-oxoethyl 2-(1,4-dioxo-3,4-dihydrophthalazin-2(1H)-yl)acetate

2-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-oxoethyl 2-(4-hydroxy-1-oxophthalazin-2(1H)-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-oxoethyl 2-(4-hydroxy-1-oxophthalazin-2(1H)-yl)acetate
IUPAC Name2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-oxoethyl 2-(1,4-dioxo-3,4-dihydrophthalazin-2(1H)-yl)acetate
Molecular FormulaC20H16N2O7
Molecular Weight396.36
SMILESO=C(OCC(C1=CC=C2OCCOC2=C1)=O)CN(N=C(O)C3=C4C=CC=C3)C4=O
InChI KeyTUPNUUPMDDHANT-UHFFFAOYSA-N
CAS No.848316-39-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACULVT358 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKNEG765 route compound structure diagram
    ACKNEG76593439-37-3 In Stock
  2. Plus
  3. ACNQFX763 route compound structure diagram
    ACNQFX7632257-64-9 In Stock
  4. Then
  5. ACULVT358 route product structure diagram
    ACULVT358848316-39-2
Inquiry

2. ACULVT358 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNQFX763 route compound structure diagram
    ACNQFX7632257-64-9 In Stock
  4. Then
  5. ACULVT358 route product structure diagram
    ACULVT358848316-39-2
Inquiry

Comments (0)